ANTIBODY MOLECULES FOR CANCER TREATMENT

The disclosure relates to anti-PD1 and anti-LAG3 antibody molecules. Compositions comprising such antibody molecules, in particular for therapeutic purposes in the field of cancer diseases are also claimed.

Saved in:
Bibliographic Details
Main Authors DAVIDSON, Walter Carroll, WURM, Melanie, YANG, Danlin, SCHAAF, Otmar, ZETTL, Markus, FORTIN, Jean-Fran‡ois, GUPTA, Pankaj, LORENZ, Ivo, CHLEWICKI, Lukasz, WOSKA Jr., Joseph Robert, GUPTA, Priyanka, PEREZ, Rocio K, CANADA, Keith A, XIAO, Haiguang, BRODEUR, Scott
Format Patent
LanguageEnglish
Published 30.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure relates to anti-PD1 and anti-LAG3 antibody molecules. Compositions comprising such antibody molecules, in particular for therapeutic purposes in the field of cancer diseases are also claimed.
Bibliography:Application Number: PH20181502429